Literature DB >> 3716427

Postmenopausal estrogens--current prescribing patterns of San Diego gynecologists.

E Barrett-Connor.   

Abstract

San Diego gynecologists were surveyed to determine 1985 prescribing patterns and indications for postmenopausal estrogens. More than 75% of the 103 respondents indicated that they prescribed estrogen for at least 75% of their recently postmenopausal patients, usually for a prolonged period. The dose and duration of estrogen were those recommended to prevent osteoporosis, which was given by all but one physician as a major indication for estrogen use. Only five gynecologists prescribed estrogen without a progestin, which was added primarily to reduce the risk of estrogen-associated endometrial cancer. These data suggest that San Diego gynecologists are well informed about the risks and benefits of estrogen-replacement therapy and are less concerned about the paucity of data concerning long-term progestin use in older women.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3716427      PMCID: PMC1306736     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  7 in total

1.  Characteristics of menopausal women: a survey of King and Pierce counties in Washington, 1973-2974.

Authors:  B V Stadel; N Weiss
Journal:  Am J Epidemiol       Date:  1975-09       Impact factor: 4.897

Review 2.  The menopause: benefits and risks of estrogen-progestogen replacement therapy.

Authors:  R D Gambrell
Journal:  Fertil Steril       Date:  1982-04       Impact factor: 7.329

Review 3.  Estrogen use and postmenopausal women: a basis for informed decisions. NIH Consensus Development.

Authors:  B Gastel; J Cornoni-Huntley; J A Brody
Journal:  J Fam Pract       Date:  1980-11       Impact factor: 0.493

4.  Noncontraceptive estrogens and progestins: use patterns over time.

Authors:  D L Kennedy; C Baum; M B Forbes
Journal:  Obstet Gynecol       Date:  1985-03       Impact factor: 7.661

5.  Prescribing estrogen during menopause: physician survey of practices in 1974 and 1981.

Authors:  B H Pasley; S J Standfast; S H Katz
Journal:  Public Health Rep       Date:  1984 Jul-Aug       Impact factor: 2.792

6.  Heart disease risk factors and hormone use in postmenopausal women.

Authors:  E Barrett-Connor; W V Brown; J Turner; M Austin; M H Criqui
Journal:  JAMA       Date:  1979-05-18       Impact factor: 56.272

Review 7.  Noncontraceptive estrogen use and cardiovascular disease.

Authors:  T L Bush; E Barrett-Connor
Journal:  Epidemiol Rev       Date:  1985       Impact factor: 6.222

  7 in total
  5 in total

1.  Prescribing of noncontraceptive estrogens and progestins in the United States, 1974-86.

Authors:  E Hemminki; D L Kennedy; C Baum; S M McKinlay
Journal:  Am J Public Health       Date:  1988-11       Impact factor: 9.308

2.  Are women using postmenopausal estrogens? A community survey.

Authors:  R B Harris; A Laws; V M Reddy; A King; W L Haskell
Journal:  Am J Public Health       Date:  1990-10       Impact factor: 9.308

3.  Past and present preferred prescribing practices of hormone replacement therapy among Los Angeles gynecologists: possible implications for public health.

Authors:  R K Ross; A Paganini-Hill; S Roy; A Chao; B E Henderson
Journal:  Am J Public Health       Date:  1988-05       Impact factor: 9.308

4.  Hormone replacement therapy: a survey of Ontario physicians' prescribing practices.

Authors:  L Elinson; M M Cohen; T Elmslie
Journal:  CMAJ       Date:  1999-09-21       Impact factor: 8.262

5.  Use of hormone replacement therapy in 1976-89 by 45-64 year old Finnish women.

Authors:  P Topo; T Klaukka; E Hemminki; A Uutela
Journal:  J Epidemiol Community Health       Date:  1991-12       Impact factor: 3.710

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.